Mass Immunisation to Eradicate Japanese Encephalitis: Real-world Evidence from Guizhou Province in 2005-2021

Overview

Journal J Virus Erad

Date 2024 Apr 8

PMID 38586471

Authors

Wan-Xue Zhang

Suye Zhao

Chunliu Pan

Yiguo Zhou

Chao Wang

Liping Rui

Juan Du

Ting-Ting Wei

Ya-Qiong Liu

Ming Liu

Qing-Bin Lu

Fuqiang Cui

Affiliations

Soon will be listed here.

Abstract

Objectives: To explore epidemiological changes of Japanese encephalitis (JE) in a long-time span and evaluate the impact of mass immunisation.

Method: Data on JE cases from hospitals and the county Centers for Disease Control and Prevention in Guizhou Province was collected between 2005 and 2021. Epidemiological changes were analyzed according to a series of policy implementations and the coronavirus disease 2019 (COVID-19) pandemic.

Results: A total of 5138 JE cases and 152 deaths were reported in Guizhou Province during 2005-2021. The average incidence and case fatality rates were 0.83/100,000 and 2.96%, respectively. The JE prevalence showed a declining trend over the years with the reduced incidence gap between age groups and narrowing of the high-epidemic regions. During the COVID-19 pandemic, the JE activity reached its nadir in 2020. The inclusion in the Expanded Program on Immunization of the JE vaccine and catch-up immunisations showed a significant impact on the JE declining incidence rate.

Conclusions: The implementation of JE immunisation programs has played a crucial role in controlling its spread. Continued efforts should be made to maintain high coverage of the JE vaccine and strengthen disease surveillance systems, ensuring JE effective control and eventual elimination.

Citing Articles

Epidemiological Features, Clinical Symptoms, and Environmental Risk Factors for Notifiable Japanese Encephalitis in Taiwan From 2008 to 2020: Retrospective Study.

Lin F, Chou Y, Hsieh C, Yu C JMIR Public Health Surveill. 2025; 11:e63053.

PMID: 39881432 PMC: 11793194. DOI: 10.2196/63053.

Genetic Characterization of Japanese Encephalitis Virus Isolates Circulating in Mosquitoes from Pig and Sheep Farms in Shanghai, China.

Zhang H, Li D, Zheng J, Zhang Y, Li Z, Liu K Animals (Basel). 2025; 14(24.

PMID: 39765557 PMC: 11672859. DOI: 10.3390/ani14243653.

Population genetic structure of Culex tritaeniorhynchus in different types of climatic zones in China.

Zhang Y, Wang H, Du J, Wang Y, Zang C, Cheng P BMC Genomics. 2024; 25(1):673.

PMID: 38969975 PMC: 11225206. DOI: 10.1186/s12864-024-10589-4.

References

Elias C, Okwo-Bele J, Fischer M . A strategic plan for Japanese encephalitis control by 2015. Lancet Infect Dis. 2008; 9(1):7. DOI: 10.1016/S1473-3099(08)70290-1. View

Umenai T, Krzysko R, Bektimirov T, ASSAAD F . Japanese encephalitis: current worldwide status. Bull World Health Organ. 1985; 63(4):625-31. PMC: 2536386. View

Song S, Yao H, Yang Z, He Z, Shao Z, Liu K . Epidemic Changes and Spatio-Temporal Analysis of Japanese Encephalitis in Shaanxi Province, China, 2005-2018. Front Public Health. 2020; 8:380. PMC: 7426712. DOI: 10.3389/fpubh.2020.00380. View

Erlanger T, Weiss S, Keiser J, Utzinger J, Wiedenmayer K . Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009; 15(1):1-7. PMC: 2660690. DOI: 10.3201/eid1501.080311. View

Surendran S, Nagulan R, Sivabalakrishnan K, Arthiyan S, Tharsan A, Jayadas T . Reduced dengue incidence during the COVID-19 movement restrictions in Sri Lanka from March 2020 to April 2021. BMC Public Health. 2022; 22(1):388. PMC: 8866919. DOI: 10.1186/s12889-022-12726-8. View

Feroldi E, Pancharoen C, Kosalaraksa P, Chokephaibulkit K, Boaz M, Meric C . Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J. 2014; 33(6):643-9. DOI: 10.1097/INF.0000000000000276. View

Agca H, Akalin H, Saglik I, Hacimustafaoglu M, Celebi S, Ener B . Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. J Infect Public Health. 2021; 14(9):1186-1190. DOI: 10.1016/j.jiph.2021.08.004. View

Bouckenooghe A, Bailleux F, Feroldi E . Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine. Hum Vaccin Immunother. 2018; 15(1):72-79. PMC: 6363153. DOI: 10.1080/21645515.2018.1515455. View

Yun S, Cho J, Ju Y, Kim S, Ryou J, Han M . Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J. 2010; 7:127. PMC: 2893154. DOI: 10.1186/1743-422X-7-127. View

10.

Cao M, Feng Z, Zhang J, Ma J, Li X . Contextual risk factors for regional distribution of Japanese encephalitis in the People's Republic of China. Trop Med Int Health. 2010; 15(8):918-23. DOI: 10.1111/j.1365-3156.2010.02563.x. View

11.

Zhao S, Li Y, Fu S, Liu M, Li F, Liu C . Environmental factors and spatiotemporal distribution of Japanese encephalitis after vaccination campaign in Guizhou Province, China (2004-2016). BMC Infect Dis. 2021; 21(1):1172. PMC: 8607706. DOI: 10.1186/s12879-021-06857-3. View

12.

Sohn Y . Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis. 2000; 6(1):17-24. PMC: 2627978. DOI: 10.3201/eid0601.000103. View

13.

Gao X, Li X, Li M, Fu S, Wang H, Lu Z . Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011. PLoS Negl Trop Dis. 2014; 8(8):e3015. PMC: 4133196. DOI: 10.1371/journal.pntd.0003015. View

14.

Shi T, Meng L, Li D, Jin N, Zhao X, Zhang X . Impact of the expanded program on immunization on the incidence of Japanese encephalitis in different regions of Mainland China: An interrupt time series analysis. Acta Trop. 2022; 233:106575. DOI: 10.1016/j.actatropica.2022.106575. View

15.

Turtle L, Solomon T . Japanese encephalitis - the prospects for new treatments. Nat Rev Neurol. 2018; 14(5):298-313. DOI: 10.1038/nrneurol.2018.30. View

16.

Choe Y, Taurel A, Nealon J, Seo H, Kim H . Systematic review of seroepidemiological studies on Japanese encephalitis in the Republic of Korea. Int J Infect Dis. 2017; 67:14-19. DOI: 10.1016/j.ijid.2017.11.023. View

17.

Minh Quan T, Thao T, Duy N, Nhat T, Clapham H . Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015. Elife. 2020; 9. PMC: 7282807. DOI: 10.7554/eLife.51027. View

18.

Yin Z, Beeler Asay G, Zhang L, Li Y, Zuo S, Hutin Y . An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine. 2012; 30(37):5569-77. DOI: 10.1016/j.vaccine.2012.05.068. View

19.

Fang Y, Zhang W, Xue J, Zhang Y . Monitoring Mosquito-Borne Arbovirus in Various Insect Regions in China in 2018. Front Cell Infect Microbiol. 2021; 11:640993. PMC: 8006455. DOI: 10.3389/fcimb.2021.640993. View

20.

Zhang L, Luan R, Jiang F, Rui L, Liu M, Li Y . Epidemiological characteristics of Japanese encephalitis in Guizhou Province, China, 1971-2009. Biomed Environ Sci. 2012; 25(3):297-304. DOI: 10.3967/0895-3988.2012.03.007. View